On track to file a Clinical Trial Application (CTA) by year end 2025, with initial clinical data expected mid-2026Important ...
On track to file a Clinical Trial Application (CTA) by year end 2025, with initial clinical data expected mid-2026Important step in developing scalable and accessible 'off-the-shelf' cell therapy for ...
An AI-driven computational toolkit, Gcoupler, integrates ligand design, statistical modeling, and graph neural networks to predict endogenous metabolites that allosterically modulate the GPCR–Gα ...
Tucson’s mystique drew me back this year on a journey that revealed more of its magic and how its seeming austerity masks an ...
Amateur Photographer on MSN
This is the best photo editing software to use in 2026
Take your images to the next level with the best photo editing software. Jon Stapley and the AP team pick top programs, ...
HCL Unica+ is transforming customer engagement for large Indian enterprises. In this interview, Iyer explained how one ...
Modern marketing is in a funny place right now. Brands have more digital tools than ever, but attention is harder to earn. Audiences scroll fast, ad fatigue is ...
AZoLifeSciences on MSN
Circular DNA Boosts Multi-Target MiRNA Therapy
Professor Dongsheng Liu of Tsinghua University, Professor Ziyang Hao of Capital Medical University, and Researcher Yuanchen Dong of the Institute of ...
Affinity was helping to finance Paramount's ( PSKY) $30/share bid for Warner Bros. ( WBD ). The private equity firm now ...
Affinity Partners, the firm founded by Donald Trump ‘s son-in-law Jared Kushner, will no longer be a part of the group of ...
Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback